Management of Covid-19 Patients During Home Isolation

NCT04368923 — Not applicable, Unknown, 60 participants, Cairo University

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Registry	NCT04368923
Status	Unknown
Phase	Not applicable
Study type	Interventional; randomized, parallel, masking: single, treatment
Enrollment	60 (Actual)
Sponsor	Cairo University (Other)
Conditions	Covid 19
Interventions	Oxygen Therapy, Physical Therapy (Device, procedure)
Dates	start 2020-03-15, primary completion 2020-06-21 (estimated), completion 2020-06-23 (estimated), first posted 2020-04-30, last updated 2020-06-23
Locations	1 site in Egypt

-Summary

This study will be concerned with managing patients of Covid-19 while being home isolated.

Expand all sections · Collapse all

+Arms and interventions

Arm	Type	Interventions	Description
Oxygen Therapy Group	Experimental	Device: Oxygen Therapy
Physical Therapy Group	Experimental	Procedure: Physical Therapy

Oxygen Therapy (Device): Patients receive oxygen therapy
Physical Therapy (Procedure): Patients receive physical therapy

+Outcome measures

Primary outcomes

Arterial Blood Gases (ABG): Partial Pressure of Oxygen and Carbon Dioxide [48 hours]
Arterial Blood Gases (ABG): Acidity Potential Hydrogen (pH) [48 hours]

Secondary outcomes

Vital Signs (Temprature) [24 hours]
Vital Signs (Respiratory Rate) [24 hours]
Vital Signs (Oxygen Saturation) [24 hours]
Vital Signs (Heart Rate) [24 hours]
Vital Signs (Blood Pressure) [24 hours]

+Eligibility

Sex: All, ages: 21 Years to 40 Years

Inclusion Criteria:

* Patients with Covid-19
* American Society of Anesthesiologists (ASA) class I
* >= 21 years old
* <= 40 years old

Exclusion Criteria:

* ASA class II, class III or class IV

+Locations (1)

Facility	City	Country	Status
M. Sedky	Cairo	Egypt

+Publications

Results publication: Adly AS, Adly MS, Adly AS. Telemanagement of Home-Isolated COVID-19 Patients Using Oxygen Therapy With Noninvasive Positive Pressure Ventilation and Physical Therapy Techniques: Randomized Clinical Trial. J Med Internet Res. 2021 Apr 28;23(4):e23446. doi: 10.2196/23446. PMID 33819166